|
|
|
|
Revolution Medicines Inc (NASDAQ: RVMD) |
|
|
|
| |
Revolution Medicines Inc Accounts Receivables Turnover Ratio from the third quarter 2026 to the third quarter 2025
Quarterly Results, Trends, Rankings, Statistics
Revolution Medicines Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the third quarter 2026 to a ratio of 3.43, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the third quarter 2026. Revolution Medicines Inc 's Accounts Receivable average collection period in the Sep 30 2026 quarter, | |